Identification of 6 Hub Proteins and Protein Risk Signature of Colorectal Cancer.

Taohua YueCheng LiuJing ZhuZhihao HuangShihao GuoYuyang ZhangHao XuYucun LiuPengyuan Wang Shanwen Chen

Published in: BioMed research international (2020)

Studies indicated that 6 hub proteins might be considered as new targets for CRC therapies, and the protein risk signature can be used to predict the OS of CRC patients.

Keyphrases

end stage renal disease
bioinformatics analysis
newly diagnosed
chronic kidney disease
ejection fraction
protein protein
peritoneal dialysis
network analysis
binding protein
amino acid
small molecule
patient reported outcomes